Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Peginterferon Alfa-2a and Ribavirin in CHC Patients with Renal Impairment
NCT02864199Phase 4Completed
- Sponsor
- Roche
- Start
- Feb 2004
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 5
01
Overview
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by Roche. Started Feb 2004; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02864199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02864199.